1263 related articles for article (PubMed ID: 31369817)
21. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract][Full Text] [Related]
22. Cancer stem cell epigenetics and chemoresistance.
Crea F; Danesi R; Farrar WL
Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
[TBL] [Abstract][Full Text] [Related]
23. Surmounting cancer drug resistance: New insights from the perspective of N
Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
25. Cancer Stem Cell (CSC) Inhibitors in Oncology-A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives.
Kharkar PS
J Med Chem; 2020 Dec; 63(24):15279-15307. PubMed ID: 33325699
[TBL] [Abstract][Full Text] [Related]
26. ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.
Begicevic RR; Falasca M
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29117122
[TBL] [Abstract][Full Text] [Related]
27. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
28. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
[TBL] [Abstract][Full Text] [Related]
29. Apoptotic and autophagic pathways with relevant small-molecule compounds, in cancer stem cells.
Zhang L; Tong X; Li J; Huang Y; Hu X; Chen Y; Huang J; Wang J; Liu B
Cell Prolif; 2015 Aug; 48(4):385-97. PubMed ID: 26013704
[TBL] [Abstract][Full Text] [Related]
30. Apoptotic death of cancer stem cells for cancer therapy.
He YC; Zhou FL; Shen Y; Liao DF; Cao D
Int J Mol Sci; 2014 May; 15(5):8335-51. PubMed ID: 24823879
[TBL] [Abstract][Full Text] [Related]
31. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
32. The bad seed: Cancer stem cells in tumor development and resistance.
Koren E; Fuchs Y
Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
[TBL] [Abstract][Full Text] [Related]
33. ABCG2: the key to chemoresistance in cancer stem cells?
An Y; Ongkeko WM
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1529-42. PubMed ID: 19708828
[TBL] [Abstract][Full Text] [Related]
34. The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance.
Chen K; Zhang C; Ling S; Wei R; Wang J; Xu X
Cell Death Dis; 2021 Sep; 12(9):835. PubMed ID: 34482364
[TBL] [Abstract][Full Text] [Related]
35. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
36. ABC transporters, drug resistance, and cancer stem cells.
Dean M
J Mammary Gland Biol Neoplasia; 2009 Mar; 14(1):3-9. PubMed ID: 19224345
[TBL] [Abstract][Full Text] [Related]
37. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
38. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes.
Ma X; Zhou J; Zhang CX; Li XY; Li N; Ju RJ; Shi JF; Sun MG; Zhao WY; Mu LM; Yan Y; Lu WL
Biomaterials; 2013 Jun; 34(18):4452-65. PubMed ID: 23518403
[TBL] [Abstract][Full Text] [Related]
39. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
40. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
